Asker acquires Baltic medtech firm Ambercell Solutions
The acquisition expands Asker's presence in the Baltics with a supply chain platform provider. It is pending regulatory approval, expected in Q4 2026.
See the latest news and media coverage for Asker. We track all announcements, press releases, and industry mentions in real time, all in one place.
European healthcare group providing medical products and solutions
asker.comLast updated
In short: Asker delivered strong 2026 growth, earned a AAA ESG rating, and expanded its European presence with multiple strategic acquisitions.
The acquisition expands Asker's presence in the Baltics with a supply chain platform provider. It is pending regulatory approval, expected in Q4 2026.
The highest possible rating highlights strong governance, ethics, and carbon performance in the healthcare sector.
Net sales rose 18% to SEK 4,686m, margin improved to 10.0%, and M&A pipeline remains strong.
Founded in 1978, the Irish distributor had 9 employees and SEK 73m revenue, complementing HSL Group's surgical products.
Medical technology company Asker rejects criticism regarding its accounting after DNB Carnegie downgraded its buy recommendation to sell, reducing by...
The shares of medical technology company Asker Healthcare Group fell by approximately 20% this Friday, after DNB Carnegie downgraded its recommendation to...
The acquisition spree continues for Asker Healthcare Group, with Med Kjemi as the latest purchase.
Asker Healthcare Group has acquired Ambercell Solutions, a Baltic provider of medical technology services and products. The company has 45 employees and...
Track Asker and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Asker and other trending companies.